InChi Code: InChI=1S/C50H69N15O9.C2H4O2/c1-3-4-16-36(59-29(2)66)44(69)65-41-25-42(67)55-20-11-10-18-35(43(51)68)60-47(72)39(23-31-26-57-34-17-9-8-15-33(31)34)63-45(70)37(19-12-21-56-50(52)53)61-46(71)38(22-30-13-6-5-7-14-30)62-48(73)40(64-49(41)74)24-32-27-54-28-58-32,1-2(3)4/h5-9,13-15,17,26-28,35-41,57H,3-4,10-12,16,18-25H2,1-2H3,(H2,51,68)(H,54,58)(H,55,67)(H,59,66)(H,60,72)(H,61,71)(H,62,73)(H,63,70)(H,64,74)(H,65,69)(H4,52,53,56),1H3,(H,3,4)/t35-,36-,37-,38+,39-,40-,41-,/m0./s1
The most common electrolyte imbalances associated with GLP-1 therapy are hypokalemia (low potassium), hyponatremia (low sodium), and hypomagnesemia (low magnesium), typically resulting from gastrointestinal losses through vomiting or diarrhea combined with reduced oral intake
Whilst generally considered safe when used as directed, paracetamol is metabolised primarily in the liver, making hepatic health a crucial consideration for anyone using this medication regularly
View full credentials and publications
At Invyncible, we believe in providing comprehensive solutions that target stubborn fat deposits, boost metabolism, and support your weight loss journey with efficacy and precision